Agency Information Collection Request; 60-Day Public Comment Request, 56963-56964 [2022-20115]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 179 / Friday, September 16, 2022 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
Children (VFC) vote on COVID–19
vaccine is scheduled. Agenda items are
subject to change as priorities dictate.
For more information on the meeting
agenda visit https://www.cdc.gov/
vaccines/acip/meetings/meetingsinfo.html.
Public Participation
Interested persons or organizations
are invited to participate by submitting
written views, recommendations, and
data. Please note that comments
received, including attachments and
other supporting materials, are part of
the public record and are subject to
public disclosure. Comments will be
posted on https://www.regulations.gov.
Therefore, do not include any
information in your comment or
supporting materials that you consider
confidential or inappropriate for public
disclosure. If you include your name,
contact information, or other
information that identifies you in the
body of your comments, that
information will be on public display.
CDC will review all submissions and
may choose to redact, or withhold,
submissions containing private or
proprietary information such as Social
Security numbers, medical information,
inappropriate language, or duplicate/
near duplicate examples of a mass-mail
campaign. CDC will carefully consider
all comments submitted into the docket.
Written Public Comment: Written
comments must be received on or before
October 20, 2022.
Oral Public Comment: This meeting
will include time for members of the
public to make an oral comment. Oral
public comment will occur before any
scheduled votes including all votes
relevant to the ACIP’s Affordable Care
Act and Vaccines for Children Program
roles. Priority will be given to
individuals who submit a request to
make an oral public comment before the
meeting according to the procedures
below.
Procedure for Oral Public Comment:
All persons interested in making an oral
public comment during the October 19–
20, 2022, ACIP meeting must submit a
request at https://www.cdc.gov/vaccines/
acip/meetings/ no later than 11:59 p.m.
EDT, October 14, 2022, according to the
instructions provided.
If the number of persons requesting to
speak is greater than can be reasonably
accommodated during the scheduled
time, CDC will conduct a lottery to
determine the speakers for the
scheduled public comment session.
CDC staff will notify individuals
regarding their request to speak by email
by October 18, 2022. To accommodate
the significant interest in participation
VerDate Sep<11>2014
16:43 Sep 15, 2022
Jkt 256001
in the oral public comment session of
ACIP meetings, each speaker will be
limited to three minutes, and each
speaker may only speak once per
meeting.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–20045 Filed 9–15–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Tick-Borne Disease
Working Group
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
As required by the Federal
Advisory Committee Act, the
Department of Health and Human
Services (HHS) is hereby giving notice
that the Tick-Borne Disease Working
Group (TBDWG) will hold a meeting.
The meeting will be open to the public
via webcast. For this meeting, the
TBDWG will review the progress of the
Working Group.
DATES: The public can view the meeting
online via webcast on December 7, 2022
from approximately 9:00 a.m. to 5:00
p.m. ET (times are tentative and subject
to change) each day. The confirmed
times and agenda items for the meeting
will be posted on the TBDWG web page
at https://www.hhs.gov/ash/advisorycommittees/tickbornedisease/meetings/
2022-12-07/ when this
information becomes available.
FOR FURTHER INFORMATION CONTACT:
James Berger, Designated Federal Officer
for the TBDWG; Office of Infectious
Disease and HIV/AIDS Policy, Office of
the Assistant Secretary for Health,
Department of Health and Human
Services, Tower Building, 1101 Wootton
Parkway, Rockville, MD 20852. Email:
tickbornedisease@hhs.gov. Phone: 202–
795–7608.
SUPPLEMENTARY INFORMATION: A link to
view the webcast can be found on the
SUMMARY:
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
56963
meeting website at https://www.hhs.gov/
ash/advisory-committees/
tickbornedisease/meetings/2022-12-07/
index.html when it becomes available.
The public will have an opportunity to
present their views to the TBDWG orally
during the meeting’s public comment
session or by submitting a written
public comment. Comments should be
pertinent to the meeting discussion.
Persons who wish to provide verbal or
written public comment should review
instructions at https://www.hhs.gov/
ash/advisory-committees/
tickbornedisease/meetings/2022-12-07/
index.html and respond by midnight
November 29, 2022 ET. Verbal
comments will be limited to three
minutes each to accommodate as many
speakers as possible during the 30minute session. Written public
comments will be accessible to the
public on the TBDWG web page prior to
the meeting.
Background and Authority: The TickBorne Disease Working Group was
established on August 10, 2017, in
accordance with section 2062 of the 21st
Century Cures Act, and the Federal
Advisory Committee Act, 5 U.S.C. app.,
as amended, to provide expertise and
review federal efforts related to all tickborne diseases, to help ensure
interagency coordination and minimize
overlap, and to examine research
priorities. The TBDWG is required to
submit a report to the HHS Secretary
and Congress on their findings and any
recommendations for the federal
response to tick-borne disease every two
years.
Dated: September 8, 2022.
James J. Berger,
Designated Federal Officer, Tick-Borne
Disease Working Group, Office of Infectious
Disease and HIV/AIDS Policy.
[FR Doc. 2022–20092 Filed 9–15–22; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier: OS–0990–New]
Agency Information Collection
Request; 60-Day Public Comment
Request
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
SUMMARY:
E:\FR\FM\16SEN1.SGM
16SEN1
56964
Federal Register / Vol. 87, No. 179 / Friday, September 16, 2022 / Notices
Comments on the ICR must be
received on or before November 15,
2022.
DATES:
Submit your comments to
Sherrette.Funn@hhs.gov or by calling
(202) 795–7714.
FOR FURTHER INFORMATION CONTACT:
When submitting comments or
requesting information, please include
the document identifier 0990–New–60D
and project title for reference, to
Sherrette A. Funn, email:
Sherrette.Funn@hhs.gov, or call (202)
795–7714 the Reports Clearance Officer.
SUPPLEMENTARY INFORMATION: Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
ADDRESSES:
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: Data
Management Standard Operating
Procedures Survey.
Type of Collection: New.
OMB No.: 0990–New.
Abstract: The Office of the Assistant
Secretary for Health, Office of Research
Integrity is requesting a new approval
from the Office of Management and
Budget of the Data Management
Standard Operating Procedures Survey.
Information from respondents to the
survey will be used to develop a Data
Management Standard Operating
Procedures toolkit that will be
disseminated to researchers, research
administrators, and research institutions
to implement. In addition, other
products will be developed to
disseminate survey results and findings
to include, social media posts, YouTube
video, webinar, and summary report for
the research community.
Likely Respondents: Biostatisticians
and Bioscience Researchers.
ANNUALIZED BURDEN HOUR TABLE
Number of
responses per
respondent
Average
burden
per response
(in hours)
Total
burden hours
Type of respondent
Data Management Standard Operating Procedures Survey.
Biostatisticians and Bioscience Researchers.
1,200
1
45/60
900
Total ...........................................
...........................................................
........................
........................
........................
900
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
[FR Doc. 2022–20115 Filed 9–15–22; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Findings of Research Misconduct;
Correction
Office of the Secretary, HHS.
ACTION: Correction of notice.
AGENCY:
This document corrects errors
that appeared in the notice published in
the August 5, 2022, Federal Register
entitled ‘‘Findings of Research
Misconduct.’’
Applicability Date: The correction
notice is applicable for the Findings of
Research Misconduct notice published
on August 5, 2022.
FOR FURTHER INFORMATION CONTACT: Dr.
Alexander Runko or Ms. Karen Gorirossi
at 240–453–8800.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Background
In FR Doc. 2022–16867 of August 5,
2022 (87 FR 48034–48036), there were
errors involving National Institutes of
Health (NIH) grant application UL1
TR000124 affecting six paragraphs on
VerDate Sep<11>2014
16:43 Sep 15, 2022
Jkt 256001
page 48035. The errors are identified
and corrected in the Correction of Errors
section below.
II. Correction of Errors
BILLING CODE 4150–31–P
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
respondents
Form name
Due to additional information
provided by the institution to the Office
of Research Integrity, it was determined
that NIH grant application UL1
TR000124 did not fund or contain
falsified/fabricated data; therefore, this
grant application has been removed
from the findings of research
misconduct reported in FR Doc. 2022–
16867. Thus, in FR Doc. 2022–16867 of
August 5, 2022 (87 FR 48034–48036),
make the following corrections:
1. On page 48035, first column, in FR
Doc. 2022–16867, first paragraph, lines
9–12, remove ‘‘UL1 TR000124
submitted to the National Center for
Advancing Translational Sciences
(NCATS), NIH.’’
2. On page 48035, first column, in FR
Doc. 2022–16867, fourth paragraph,
lines 14–15, remove ‘‘UL TR000124
submitted to NCATS, NIH.’’
3. On page 48035, first column, in FR
Doc. 2022–16867, fifth paragraph, lines
5–6, change ‘‘eleven (11) grant
applications’’ to ‘‘ten (10) grant
applications.’’
4. On page 48035, first column, in FR
Doc. 2022–16867, seventh paragraph,
lines 1–2, and second column, in FR
Doc. 2022–16867, first paragraph, lines
1–3, remove ‘‘UL1 TR000124, ‘UCLA
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
Clinical and Translational Science
Institute,’ submitted to NCATS, NIH,
Awarded Project Dates: June 1, 2011–
August 31, 2016.’’
5. On page 48035, second column, in
FR Doc. 2022–16867, thirteenth
paragraph, line 1, remove ‘‘Figure 6 of
UL1 TR000124.’’
Dated: September 13, 2022.
Wanda K. Jones,
Acting Director, Office of Research Integrity,
Office of the Assistant Secretary for Health.
[FR Doc. 2022–20070 Filed 9–15–22; 8:45 am]
BILLING CODE 4150–31–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Tick-Borne Disease
Working Group
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
As required by the Federal
Advisory Committee Act, the
Department of Health and Human
Services (HHS) is hereby giving notice
that the Tick-Borne Disease Working
Group (TBDWG) will hold a meeting.
The meeting will be open to the public
via webcast. For this meeting, the
TBDWG will review and vote upon the
SUMMARY:
E:\FR\FM\16SEN1.SGM
16SEN1
]]>Agencies
[Federal Register Volume 87, Number 179 (Friday, September 16, 2022)]
[Notices]
[Pages 56963-56964]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-20115]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Document Identifier: OS-0990-New]
Agency Information Collection Request; 60-Day Public Comment
Request
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement of the Paperwork Reduction
Act of 1995, the Office of the Secretary (OS), Department of Health and
Human Services, is publishing the following summary of a proposed
collection for public comment.
[[Page 56964]]
DATES: Comments on the ICR must be received on or before November 15,
2022.
ADDRESSES: Submit your comments to [email protected] or by calling
(202) 795-7714.
FOR FURTHER INFORMATION CONTACT: When submitting comments or requesting
information, please include the document identifier 0990-New-60D and
project title for reference, to Sherrette A. Funn, email:
[email protected], or call (202) 795-7714 the Reports Clearance
Officer.
SUPPLEMENTARY INFORMATION: Interested persons are invited to send
comments regarding this burden estimate or any other aspect of this
collection of information, including any of the following subjects: (1)
The necessity and utility of the proposed information collection for
the proper performance of the agency's functions; (2) the accuracy of
the estimated burden; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) the use of
automated collection techniques or other forms of information
technology to minimize the information collection burden.
Title of the Collection: Data Management Standard Operating
Procedures Survey.
Type of Collection: New.
OMB No.: 0990-New.
Abstract: The Office of the Assistant Secretary for Health, Office
of Research Integrity is requesting a new approval from the Office of
Management and Budget of the Data Management Standard Operating
Procedures Survey. Information from respondents to the survey will be
used to develop a Data Management Standard Operating Procedures toolkit
that will be disseminated to researchers, research administrators, and
research institutions to implement. In addition, other products will be
developed to disseminate survey results and findings to include, social
media posts, YouTube video, webinar, and summary report for the
research community.
Likely Respondents: Biostatisticians and Bioscience Researchers.
Annualized Burden Hour Table
----------------------------------------------------------------------------------------------------------------
Average
Type of Number of Number of burden per Total burden
Form name respondent respondents responses per response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
Data Management Standard Biostatisticians 1,200 1 45/60 900
Operating Procedures Survey. and Bioscience
Researchers.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 900
----------------------------------------------------------------------------------------------------------------
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance Officer, Office of the
Secretary.
[FR Doc. 2022-20115 Filed 9-15-22; 8:45 am]
BILLING CODE 4150-31-P
